Abbott Laboratories

New York Stock Exchange
Back to all articles
Bearish -50

Protesters Storm U.S. Consul General's Residence In Lagos, Accuse Abbott Diagnostics Of Undermining Court Case Against Nigerian Firm

AI-generated analysis

📍 Civil society groups staged a protest at the residence of the U.S. Consul General in Lagos on Tuesday.

⚖️ Demonstrators accuse Abbott Diagnostics of attempting to undermine an ongoing court case against Acouns Nigeria Limited.

💊 The dispute centers on the Determine HIV 1/2 Test Kit, a product widely used in Nigeria for decades.

🏢 The protest occurred at 25 Modupe Alakija Crescent, Ikoyi, Lagos, where concerns were raised about judicial authority and corporate accountability.

⚖️ Protesters stated that Acouns Nigeria Limited played a pioneering role in introducing and establishing the Determine HIV Test Kit over more than three decades.

💰 Acouns alleges Abbott unlawfully terminated distribution agreements while benefiting from regulatory registrations and market goodwill developed by Acouns.

📜 The legal dispute is referenced as Suit No. FHC/L/CS/1528/2023, where Acouns seeks damages estimated at approximately $186 million.

⚠️ Civil society groups express concern that commercial activities involving the product have continued despite existing court orders and an interlocutory injunction.

🔄 Protesters argue that attempts to rebrand or repackaging the product may be used to circumvent restrictions imposed by the Federal High Court.

🏭 A proposed manufacturing project linked to the Determine HIV Test Kit has sparked further concern about excluding Acouns from discussions.

🤝 The groups demand recognition and fair accommodation of the contributions made by indigenous Nigerian enterprises in building the market.

⚖️ Protesters emphasize that no corporation should place itself above judicial authority and that court orders must be respected until overturned.

📢 Five specific demands were issued, including strict compliance with court orders, transparency during litigation, and promotion of genuine local partnerships.

🇳🇬 The controversy highlights broader challenges for indigenous Nigerian companies regarding local content policies and fair treatment after creating value.

🏥 The healthcare sector's integrity is cited as dependent on trust, long-term partnerships, and strict compliance with legal processes.

⚖️ While acknowledging the right of all parties to present their cases, protesters insist that existing judicial directives must be followed pending final determination.

📉 The groups warn that such developments could discourage local entrepreneurship and investment if Nigerian businesses are excluded after market creation.

🔍 Transparency and integrity within the healthcare sector are stressed as essential for resolving disputes involving life-saving medical products.

👁️ The business community, healthcare sector, and Nigerian public are noted to be closely monitoring the progress of this matter.

Bullish Signals
  • Acouns Nigeria Limited played a pioneering role for more than three decades in introducing, promoting, distributing, and establishing the Determine HIV 1/2 Test Kit throughout Nigeria.
  • The company invested significant resources, expertise, infrastructure, and market development efforts to transform the Determine brand into one of the most recognised diagnostic products in the country.
  • Acouns was instrumental in obtaining regulatory approvals and building the distribution network that enabled the product to reach millions of Nigerians.
  • The Determine HIV Test Kit has been widely used across Nigeria for decades and is a trusted diagnostic tool across the country.
Risk Factors
  • Abbott Diagnostics is accused of attempting to sidestep an ongoing court case (Suit No. FHC/L/CS/1528/2023) by pursuing a rebranded manufacturing project for the Determine HIV 1/2 Test Kit in Nigeria while litigation remains pending.
  • The company faces allegations of unlawfully terminating its distribution arrangement with Acouns Nigeria Limited, which has been distributing the kit for over three decades.
  • Abbott is accused of disregarding an interlocutory injunction that restrains commercial activities related to the product while the dispute is being resolved by the Federal High Court in Lagos.
  • The company is under scrutiny for attempting to preserve commercial benefits through restructuring or rebranding despite court orders, raising concerns about undermining judicial authority.
  • Acouns Nigeria Limited alleges it invested significant resources and built the distribution network over decades, yet claims Abbott is excluding them from a new manufacturing initiative.
  • The dispute involves a potential damages claim of approximately $186 million against Abbott Diagnostics for alleged unlawful termination of agreements.
  • Civil society groups warn that such actions could discourage local entrepreneurship and undermine trust in the judiciary within Nigeria's healthcare sector.
Full Analysis
Protesters and civil society groups in Lagos staged a demonstration at the residence of the U.S. Consul General on Tuesday, accusing Abbott Diagnostics of undermining an ongoing court case against Acouns Nigeria Limited regarding the Determine HIV 1/2 Test Kit. The demonstrators argue that Abbott is attempting to sidestep judicial authority by pursuing a rebranded manufacturing project for the product in Nigeria while litigation remains pending before the Federal High Court in Lagos under Suit No. FHC/L/CS/1528/2023. The core of the dispute involves allegations that Abbott unlawfully terminated its distribution arrangement with Acouns, which has been distributing the kit for over three decades, and is now seeking to preserve commercial benefits through restructuring or rebranding despite an interlocutory injunction restraining such activities. Protesters emphasize that Acouns invested significant resources in developing the Nigerian market, obtaining regulatory approvals, and building the distribution network, and they contend that excluding them from a new manufacturing initiative disregards their historical contributions and local content principles. The groups demand strict compliance with existing court orders, transparency regarding any commercial activities connected to the product while litigation is ongoing, and recognition of indigenous enterprise contributions to Nigeria's healthcare sector. They warn that such actions could discourage local entrepreneurship and undermine trust in the judiciary, urging all parties to respect judicial authority and pursue solutions that uphold justice and fairness for the long-term interests of Nigeria.